As founder and CEO of Senescence Life Sciences (“Senescence”), Dr. Watson remains on the cutting-edge of neuroscience as the company looks to research, develop and commercialize safe, effective and scientifically proven neuroprotective compounds that address age-related cognitive decline. Under his leadership, Senescence has won a spot as one of Singapore’s Top 20 Hottest Start-ups in 2017, one of the 4 top start-ups in nutrition in Asia and one of the top 12 global nutritional start-ups as selected by DSM in San Francisco 2018. Dr. Watson has also been recognized as one of the Top 10 Influencers in Healthcare under the age of 40 in Singapore, and one of the top entrepreneurs under 35 at the Transpacific Entrepreneurial Conference in Hong Kong. Dr. Watson is also currently on the Steering Committee of the ASSIST Study in the United States, a landmark population health study collecting cognitive and brain health data digitally.